CNS Drugs

Role of Zinc in the Pathogenesis of Attention-Deficit Hyperactivity Disorder: Implications for Research and Treatment
pp. 721-728(8)
Authors: Lepping, Peter; Huber, Markus

Management of Neuropsychiatric Symptoms in People with Dementia
pp. 729-739(11)
Authors: Ballard, Clive; Corbett, Anne

The Association between Conventional Antidepressants and the Metabolic Syndrome: A Review of the Evidence and Clinical Implications
pp. 741-753(13)
Authors: McIntyre, Roger S.; >Ka Young Park,; Law, Candy W.Y.; Sultan, Farah; Adams, Amanda; >Maria Teresa Lourenco,; Lo, Aaron K.S.; Soczynska, Joanna K.; Woldeyohannes, Hanna; Alsuwaidan, Mohammad; Yoon, Jinju; Kennedy, Sidney H.

Effects of Guanfacine Extended Release on Oppositional Symptoms in Children Aged 6-12 Years with Attention-Deficit Hyperactivity Disorder and Oppositional Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial
pp. 755-768(14)
Authors: Connor, Daniel F.; Findling, Robert L.; Kollins, Scott H.; Sallee, Floyd; López, Frank A.; Lyne, Andrew; Tremblay, Gerald

Escitalopram: A Review of its Use in the Management of Major Depressive Disorder in Adults
pp. 769-796(28)
Authors: Garnock-Jones, Karly P.; McCormack, Paul L.

Pharmacoeconomic Spotlight on Varenicline as an Aid to Smoking Cessation†
pp. 797-800(4)
Authors: Keating, Gillian M.; Lyseng-Williamson, Katherine A.

Carotid Intima-Media Thickness: A Predictor of Response to Cholinesterase Inhibitors in Alzheimer's Disease?
pp. 801-803(3)
Author: Saleh, DrChristian

The Author's Reply
pp. 803-804(2)
Author: Modrego, Pedro J.